MedTrace Logo

Anti-hypertensive Medication Dosing Regimen in Effective Blood Pressure Control

NCT01669928 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 103

Last updated 2021-03-08

Study results available
· View outcomes & findings →

Summary

A randomised crossover trial of anti-hypertensive medication dosing regimen in effective blood pressure control.

To investigate whether there is a difference in 24 hour blood pressure (BP) control when antihypertensive medications are taken in the morning compared with the evening.

Conditions

Interventions

DRUG

Anti-hypertensive Medication -

Patients will be taking their routine blood pressure lowering medication prescribed by their GP, different patients will be using different blood pressure lowering medication. Dosing regimen either in the morning (between 06.00 and 11.00) or in the evening (between 18.00 and 23.00).

Sponsors & Collaborators

  • Aristotle University Of Thessaloniki

    collaborator OTHER

  • Imperial College London

    lead OTHER

Principal Investigators

  • Neil Poulter, MRCS LRCP MBBS MRCP MSc FRCP · Imperial College London

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Greece
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01669928 on ClinicalTrials.gov